Posted by Admin | 7:57 AM

In 2007, we first discussed the case of the amazing pricing of H P Acthar, a very old drug of questionable usefulness, as an example of the...

Labels: ACTH, deception, executive compensation, health care prices, institutional conflicts of interest, key opinion leaders, manipulating clinical research, marketing, Questcor, suppression of medical research

Posted by Admin | 8:00 PM

The hospital CEO compensation bubble continues to grow. As the year draws to a close, I have found another set of stories about outsized pa...

Labels: executive compensation, health care bubble, health care prices, logical fallacies, perverse incentives

Posted by Admin | 1:07 PM

Newt Gingrich's rise to the top of the pack of Republican contenders for the US presidency has earned him increased scrutiny.  The resul...

Labels: conflicts of interest, electronic medical records, health care prices, health policy, irrational exuberance, public relations, revolving doors, stealth health policy advocacy

Posted by Admin | 2:25 PM

Health care organizations are now most often run by people with management, not clinical backgrounds.  It seems like business schools have t...

Labels: Duke University, generic management, generic managers, health care prices, managers' coup d'etat, marketing, medical devices, SSM Health Care, Tenet, University of Chicago